OSCAR HEALTH INC - CLASS A (OSCR) Stock Analyst Ratings
NYSE:OSCR - New York Stock Exchange, Inc. - US6877931096 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 73% to OSCR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.71. This target is -2.31% below the current price.
OSCR was analyzed by 16 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about OSCR.
In the previous month the buy percentage consensus was at a similar level.
OSCR was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-25 | Baird | Downgrade | Outperform -> Neutral |
| 2025-07-23 | Barclays | Maintains | Underweight -> Underweight |
| 2025-07-15 | UBS | Downgrade | Neutral -> Sell |
| 2025-07-11 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2025-07-02 | Barclays | Initiate | Underweight |
| 2025-06-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-13 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-12-10 | Jefferies | Initiate | Underperform |
| 2024-11-06 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2024-10-07 | UBS | Initiate | Neutral |
| 2024-09-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-26 | Piper Sandler | Initiate | Overweight |
| 2024-06-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-30 | Baird | Initiate | Outperform |
| 2024-05-30 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-05-20 | B of A Securities | Maintains | Buy -> Buy |
| 2024-05-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-03-22 | Raymond James | Initiate | Outperform |
| 2024-02-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-02 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-08-30 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-09 | Credit Suisse | Maintains | Outperform -> Outperform |
| 2023-07-14 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-13 | Wells Fargo | Maintains | Overweight |
| 2023-06-06 | B of A Securities | Upgrade | Underperform -> Neutral |